The Dutch government has expanded its foreign direct investment screening to safeguard its artificial intelligence and biotechnology sectors amid rising geopolitical tensions.
This significant update to the Screening of Investments, Mergers and Acquisitions Act, originally established to protect critical infrastructure, now encompasses a wider range of technologies. The forthcoming regulations will subject foreign investments in AI, biotech, advanced materials, nanotechnology, and medical isotopes to rigorous scrutiny. The Bureau Toetsing Investeringen (BTI) will have the authority to pause acquisitions and investigate ownership structures, ultimately blocking transactions that could jeopardize national security.
The expansion is largely influenced by the Wennink report, which warns against economic dependency on a few non-European powers, emphasizing the importance of maintaining control over strategic technologies. Policymakers recognize that AI and biotechnology are pivotal for future security in areas such as food supply and healthcare, positioning intellectual property as a key asset in geopolitical dynamics.
This regulatory shift not only affects foreign investors but also imposes new compliance challenges for domestic transactions involving sensitive sectors. As the Netherlands reinforces its technological sovereignty, other nations, particularly in Africa, are urged to observe these developments. The global landscape is shifting towards protectionism, raising critical questions about innovation, capital flow, and national security in emerging markets.